Profile
Eric Victory is currently Director at Licensing Executives Society USA & Canada, Inc. and Vice President-Corporate Development at Aurinia Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Victory was Vice President at AstraZeneca PLC from 2002 to 2020.
Education includes undergraduate studies at Stanford University and an MBA from Northwestern University.
Eric Victory active positions
| Companies | Position | Start |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/11/2024 |
Licensing Executives Society USA & Canada, Inc.
Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Director/Board Member | - |
Former positions of Eric Victory
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2020 |
Training of Eric Victory
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Licensing Executives Society USA & Canada, Inc.
Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Commercial Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
- Stock Market
- Insiders
- Eric Victory
















